- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Transition Cell Cancer in Japan
Total 1682 results
-
Kyushu UniversityRecruitingGastric Cancer | Pancreatic CancerJapan
-
GlaxoSmithKlineCompleted
-
Wakayama Medical UniversityCompleted
-
Nihon Pharmaceutical Co., LtdCompleted
-
Tokyo Metropolitan Oncology GroupUnknown
-
SymBio PharmaceuticalsCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
Keio UniversityMerck Sharp & Dohme LLC; Ohara Pharmaceutical Co., Ltd.Recruiting
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
AbbVieActive, not recruitingNon Small Cell Lung CancerUnited States, Australia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Taiwan
-
Kansai Hepatobiliary Oncology GroupUnknownBiliary Tract CancerJapan
-
Kansai Hepatobiliary Oncology GroupCompleted
-
Tokyo UniversityCompletedGastric CancerJapan
-
TakedaCompleted
-
Translational Research Center for Medical Innovation...Jikei University School of MedicineCompleted
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicJapan
-
AbbVieRecruitingNon-Small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Japan, Israel, Korea, Republic of
-
Novartis PharmaceuticalsTerminatedMelanoma | Head and Neck Cancer | Pancreatic Cancer | Urothelial Cancer | NSCLC, Non Small Cell Lung Cancer | RCC, Renal Cell Cancer | DLBCL, Diffused Large B Cell Lymphoma | MSS, Microsatellite Stable Colon Cancer | TNBC, Triple Negative Breast Cancer | mCRPC, Metastatic Castration Resistant Prostate...Belgium, Italy, Taiwan, Germany, Spain, United States, Argentina, Australia, Austria, Czechia, France, Japan, Netherlands, Switzerland, Singapore
-
Okayama UniversityMerck Sharp & Dohme LLCRecruitingBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | BRCA1 Mutation | BRCA2 Mutation | BRCA Mutation | BRCA-Associated Breast CarcinomaJapan
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Kyowa Kirin Co., Ltd.CompletedPeripheral T/NK-cell LymphomaJapan
-
Fukushima Medical UniversityKanagawa Cancer CenterUnknown
-
Wakayama Medical UniversityCompleted
-
Japanese Foundation for Cancer ResearchHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerPhilippines, Thailand, France, Korea, Republic of, Hong Kong, United States, Turkey, Malaysia, Taiwan, Brazil, Serbia, Greece, Slovakia, Peru, South Africa, Mexico, Vietnam, Bangladesh
-
TakedaCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Nihon Pharmaceutical Co., LtdCompletedGastric Cancer | Gastric Adenoma | Colon Nos Polypectomy Tubular AdenomaJapan
-
Sumitomo Pharma Co., Ltd.CompletedMetastatic Colorectal CancerJapan
-
AbbVieCompletedAdvanced Solid Tumors CancerJapan
-
Japanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerJapan
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
Nihon UniversityCompleted
-
AstraZenecaCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingMature B-cell NeoplasmsJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSafety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer (CheckMate 907)Non-Small Cell Lung CancerUnited States, Canada, Japan, Romania, South Africa
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedMetastatic Breast CancerJapan
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungJapan
-
Kansai Hepatobiliary Oncology GroupCompleted
-
Osaka UniversityRecruiting
-
Osaka UniversityRecruitingThyroid CancerJapan
-
Shizuoka Cancer CenterUnknown
-
Invitae CorporationNational Cancer Center Hospital EastRecruiting
-
Wakayama Medical UniversityUnknown
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell LungJapan
-
Bristol-Myers SquibbRecruitingMelanoma | Carcinoma, Renal Cell | Cervical Cancer | Pancreatic Adenocarcinoma | Ovarian Neoplasms | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Urothelial Carcinoma | Microsatellite Stable Colorectal Cancer | Non-Small-Cell Lung Cancer | Gastric/Gastroesophageal Junction...United States, Australia, Italy, Germany, Spain, Canada, Israel, Japan